entera-health
  • Products
    • ImmunoLin®
    • EnteraGam®
    • NutraGamax
  • News & Events
    • COVID-19 Clinical Trial
  • Partner With Us
  • Who We Are
  • Reference Library
  • Contact Us
Select Page

Entera Health Announces Approval of COVID-19 Clinical Trial using EnteraGam in Spain

by Christopher Detzel | Oct 21, 2020 | Covid-19

Entera Health, in cooperation with Lemus Buhils, has received IRB approval to conduct a clinical trial in Barcelona Spain using EnteraGam to manage the symptoms associated with COVID-19 infections. The trial titled “Randomized Open-Label Clinical Study Evaluating the...

Recent Posts

  • Entera Health Announces Approval of COVID-19 Clinical Trial using EnteraGam in Spain

Recent Comments

    Archives

    • October 2020

    Categories

    • Covid-19

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    CONTACT
    TERMS OF SERVICE
    PRIVACY POLICY

    Claims have not been reviewed by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease or disorder. Not all statements may be applicable in all geographies. Certain product labeling and associated claims may differ based on regional regulatory requirements.

    • Twitter
    © 2019 Entera Health, LLC. All Rights Reserved. Iowa Web Design by Webspec Design